Nuclear localization of active HGF receptor Met in aggressive MDA-MB231 breast carcinoma cells

Carcinogenesis

Volumn 30, Issue 6, 2009, Pages 937-945

  Matteucci, Emanuela ^a   Bendinelli, Paola ^a   Desiderio, Maria Alfonsina ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; MEMBRANE PROTEIN; PROTEIN JXTM3; SCATTER FACTOR; TRANSCRIPTION FACTOR GAL4; TRANSCRIPTION FACTOR YAP1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; WW DOMAIN CONTAINING OXIDOREDUCTASE;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA METHYLATION; GENE CONSTRUCT; GENE FUNCTION; GENE LOCATION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL NUCLEUS; EPIGENESIS, GENETIC; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; NEOPLASM INVASIVENESS; OXIDOREDUCTASES; PHOSPHOPROTEINS; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-YES; RECEPTORS, GROWTH FACTOR; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEINS;

EID: 66749186616     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp080     Document Type: Article

References (38)

1. Firon,M. et al. (2000) Dominant negative Met reduces tumorigenicity-metastasis and increases tubule formation in mammary cells. Oncogene, 19, 2386-2397.
2. Benvenuti,S. et al. (2007) The Met receptor tyrosine kinase in invasion and metastasis. J. Cell. Physiol., 213, 316-325.
3. Kopfstein,L. et al. (2006) Metastasis: Cells autonomous mechanisms versus contributions by the tumor microenvironment. Cell. Mol. Life Sci., 63, 449-468.
4. Jiang,W.G. et al. (2001) A hammerhead ribozyme suppresses expression of hepatocyte growth factor/scatter factor receptor c-MET and reduces migration and invasiveness of breast cancer cells. Clin. Cancer Res., 7, 2555-2562.
5. Danilkovitch-Miagkova,A. et al. (2002) Dysregulation of Met receptor tyrosine kinase activity in invasive tumors. J. Clin. Invest., 109, 863-867.
6. Knudsen,B.S. et al. (2008) Showering c-Met-dependent cancers with drugs. Curr. Opin. Genet. Dev., 18, 87-96.
7. Wolf,K. et al. (2008) Compensation mechanism in tumor cell migration: Mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J. Cell Biol., 160, 267-277.
8. Yamaguchi,H. et al. (2005) Cell migration in tumors. Curr. Opin. Cell Biol., 17, 559-564.
9. Betapudi,V. et al. (2006) Distinct roles of nonmuscle myosin II isoforms in the regulation of MDA-MB231 breast cancer cell spreading and migration. Cancer Res., 66, 4725-4733.
10. Ridolfi,E. et al. (2008) Inhibitory effect of HGF on invasiveness of aggressive MDA-MB231 breast carcinoma cells, and role of HDACs. Br. J. Cancer, 99, 1623-1634.
11. Bernards,R. et al. (2002) A progression puzzle. Nature, 418, 823.
12. Ramaswamy,S. et al. (2003) A molecular signature of metastasis in primary solid tumors. Nat. Genet., 33, 49-54.
13. Ducasse,M. et al. (2006) Epigenetic aberrations and cancer. Mol. Cancer, 5, 60-70.
14. Polyak,K. (2007) Breast cancer: Origins and evolution. J. Clin. Invest., 117, 3155-3163.
15. Carpenter,G. (2003) Nuclear localization and possible function of receptor tyrosine kinases. Curr. Opin. Cell Biol., 15, 143-148.
16. Tanaka,N. et al. (2008) Endosomal sorting complex required for transport proteins in cancer pathogenesis, vescicular transport, and non-endosomal functions. Cancer Sci., 99, 1293-1303.
17. Aqeilan,R.I. et al. (2005) WW Domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function. Cancer Res., 65, 6764-6772.
18. Aqeilan,R.I. et al. (2007) Association of Wwox with ErbB4 in breast cancer. Cancer Res., 67, 9330-9336.
19. Kang,J.Y. et al. (2003) Tissue microarray analysis of hepatocyte growth factor-Met pathway components reveals a role of Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of nodenegative breast cancer. Cancer Res., 63, 1101-1105.
20. Ludes-Meyers,J.H. et al. (2003) WWOX, the common chromosomal fragile site, FRA16D, cancer gene. Cytogenet. Genome Res., 100 101-110.
21. Pluciennik,E. et al. (2006) WWOX-the FRA16D cancer gene: expression correlation with breast cancer progression and prognosis. Eur. J. Surg. Oncol., 32, 153-157.
22. Oka,T. et al. (2008) Duality of YAP: An oncogene and the promoter of apoptosis. In; Georgescu,M.M. (ed.) Adaptor Proteins and Cancer Transworld Research Network, Kerala, India, pp. 209-218.
23. Matteucci,E. et al. (2007) c-Src/histone deacetylase 3 interaction is crucial for hepatocyte growth factor dependent decrease of CXCR4 expression in highly invasive breast tumor cells. Mol. Cancer Res. 5, 833-845.
24. Komuro,A. et al. (2003) WW Domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus. J. Biol. Chem., 278, 33334-33341.
25. Tacchini,L. et al. (2001) Hepatocyte growth factor signalling stimulates hypoxia inducible factor-1 (HIF-1) activity in HepG2 hepatoma cells. Carcinogenesis, 22, 1363-1371.
26. Pozner-Moulis,S. et al. (2006) Met, the hepatocyte growth factor receptor, localizes to the nucleus in cells at low density. Cancer Res., 66, 7976-7982.
27. Tacchini,L. et al. (2000) Hepatocyte growth factor signal coupling to various transcription factors depends on triggering of Met receptor and protein kinase transducers in human hepatona cells HepG2. Exp. Cell Res., 256, 272-281.
28. Maroni,P. et al. (2007) HGF induces CXCR4 and CXCL12-mediated tumor invasion through ETS1 and NF-κB. Carcinogenesis, 28, 267-279.
29. Basu,S. et al. (2003) Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Mol. Cell, 11, 11-23.
30. Gomes,D.A. et al. (2008) c-Met must translocate to the nucleus to initiate calcium signals. J. Biol. Chem., 283, 4344-4351.
31. Ni,C.-Y. et al. (2001) γ-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science, 294 2179-2181.
32. Matteucci,E. et al. (2006) Hepatocyte growth factor differently influences Met-E-cadherin phosphorylation and downstream signaling pathway in two models of breast cells. Cell. Mol. Life Sci., 63 2016-2026.
33. Liang,Z. et al. (2005) Silencing of CXCR4 blocks breast cancer metastasis. Cancer Res., 65, 967-971.
34. Schlessinger,J. et al. (2006) Nuclear signaling by receptor tyrosine kinases: The first robin of spring. Cell, 127, 45-48.
35. Kermorgant,S. et al. (2003) Protein kinase C controls microtubule-based traffic but not proteasomal degradation of c-Met. J. Biol. Chem., 278, 28921-28929.
36. Nakayama,S. et al. (2008) Role of WWOX gene, encompassing fragile region, FRA16D, in suppression of pancreatic carcinoma cells. Cancer Sci., 99, 1370-1376.
37. Ye,K. (2005) PIKE/nuclear PI 3-kinase signaling in preventing programmed cell death. J. Cell. Biochem., 96, 463-472.
38. Desiderio,M.A. (2007) Hepatocyte growth factor in invasive growth of carcinomas. Cell. Mol. Life Sci., 64, 1341-1354.